Investors

MannKind Corporation (Nasdaq:MNKD ) is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Sign up to Receive E-mail Alerts for:

• Press Releases
• Annual Reports
• Quarterly Reports

Committee Charters	Policy Statements
Audit Committee	Policy Regarding Stockholder Recommendations of Director Nominees
Compensation Committee	Process of Security Communications with the Board of Directors
Nominating & Corporate Governance Committee

 Adobe Acrobat Reader
Read Adobe PDF files on your desktop or on the Web.